Tarleton welcomes new client CRDG
The Cannabinoid Research and Development Group (CRDG), a research strategy group seeking to make the UK the leader in global pharmaceutical cannabinoid R&D, has appointed Tarleton Communications to handle the public relations activity around its landmark report launch.
The CRDG brings together industry, academia and scientists and is co-chaired by former Life Sciences Minister George Freeman MP and former Association of the British Pharmaceutical Industry (ABPI) Director General Professor Trevor Jones.
The CRDG’s landmark report, unveiled at the Royal Society of Medicine on 15 July 2024 makes a series of 10 important recommendations designed to make the UK the leader in pharmaceutical cannabinoid R&D activity.
“I’m delighted that the CRDG have appointed Tarleton Communications to manage the PR for this important report launch. The CRDG bring together a world class team and this report is well researched, persuasive and realistic. I’m looking forward to working with the team to secure coverage for this important report and the subsequent progress the group will undoubtedly make.”